Evommune, Inc. Share Price
NASDAQ: EVMN
Live Evommune, Inc. Share Price Chart
O H L
Evommune, Inc. Performance Overview
Days Range
▼
$9.34Low
$9.39High
Markets Today
| Previous Close | $9.37 |
|---|---|
| Open | $9.39 |
| Volume | 229,060 |
| Day's Range | $9.34 - $9.39 |
| 52W Range | NA |
| Market Cap | $340.06 M |
Historical Performance
| 1M Returns | -34.11 |
|---|---|
| 3M Returns | -56.13 |
| 6M Returns | -61.10 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Evommune, Inc. Fundamentals
| Market Cap | $340.06 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $13.00 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-79.68 M |
| Profit Margin | -529.77 |
| Market Cap | $340.06 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $13.00 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-79.68 M |
| Profit Margin | -529.77 |
Evommune, Inc. Profit & Loss
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 |
| Operating Income | -$29.72 M | -$23.95 M | -$34.90 M |
| EBITDA | -$29.39 M | -$23.61 M | -$34.34 M |
| Interest Expense | $0 | -$4.00 K | $0 |
| Depreciation | $326.00 K | $349.00 K | $552.00 K |
| Income Before Tax | -$28.27 M | -$21.67 M | -$32.25 M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income + | -$28.27 M | -$21.67 M | -$32.25 M |
| Net Profit Margin | - | - | - |
Evommune, Inc. Financials Balance Sheet In USD
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Share Capital | $3.00 K | $4.00 K | $4.00 K |
| Reserve & Surplus | -$221.09 M | -$242.76 M | -$275.01 M |
| Non-Current Liabilities | $1.47 M | $7.30 M | $6.87 M |
| Current Liabilities | $17.91 M | $10.60 M | $17.49 M |
| Total Liabilities | $19.38 M | $17.90 M | $24.36 M |
| Fixed Assets | $994.00 K | $1.64 M | $1.65 M |
| Current Assets | $153.48 M | $215.85 M | $204.25 M |
| Total Assets | $224.95 M | $322.45 M | $301.95 M |
Evommune, Inc. Cash Flow
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Net Income | -$28.27 M | -$21.67 M | -$32.25 M |
| Operating Cash Flow | -$16.70 M | -$27.50 M | -$20.32 M |
| Investing Cash Flow | -$122.90 M | -$85.36 M | $31.29 M |
| Financing Cash Flow | $156.85 M | $117.11 M | $532.00 K |
| Change in Cash | $17.25 M | $4.25 M | $11.51 M |
Evommune, Inc. Return Calculator
The Evommune, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Evommune, Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Popular Stocks
FAQs
What is the share price of Evommune, Inc. today?
Evommune, Inc. (EVMN) share price as of September 18, 2026 is $9.40. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Evommune, Inc.?
Yes, Indian Investors can invest in the Evommune, Inc. (EVMN) Share by opening an international trading account with Angel One.
How can I purchase Evommune, Inc. shares in India?
Purchasing Evommune, Inc. (EVMN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Evommune, Inc. (EVMN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Evommune, Inc.?
Yes, you can purchase fractional shares of Evommune, Inc. (EVMN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Evommune, Inc.?
The market capitalization of Evommune, Inc. on September 18, 2026, is $340.06 M.
In which sector Evommune, Inc. belongs?
Evommune, Inc. operates in the null sector, specifically in the null industry.
What documents are required to invest in Evommune, Inc. stocks?
In order to invest in Evommune, Inc. (EVMN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
